VAL201 Clinical trial update
VAL
Tue, 21 Jul 2015, 12:15pm BST
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
Dr George Morris, COO, provides an update on the VAL201 trial which is on track and with the approved incremental dose escalation has continued to demonstrate safety and tolerability, with no significant adverse effects recorded.